Barriers to Adherence in Juvenile Idiopathic Arthritis: A Multicenter Collaborative Experience and Preliminary Results
Authors:
- Leslie A. FavierLFLeslie A. Favier
- Janalee TaylorJTJanalee Taylor
- Kristin Loiselle RichKRKristin Loiselle Rich
- Karla B. JonesKJKarla B. Jones
- Sheetal S. VoraSVSheetal S. Vora
- Julia G. HarrisJHJulia G. Harris
- Beth S. GottliebBGBeth S. Gottlieb
- Lisa RobbinsLRLisa Robbins
- Jamie T. LaiJLJamie T. Lai
- Tzielan LeeTLTzielan Lee
- Melanie KohlheimMKMelanie Kohlheim
- Jennifer GillJGJennifer Gill
Open Access
- 1 February 2018
- journal article
- research article
- Published by The Journal of Rheumatology in The Journal of Rheumatology
- Vol. 45 (5) , 690-696
Abstract
Objective.: Nonadherence is currently an underrecognized and potentially modifiable obstacle to care in juvenile idiopathic arthritis (JIA). The purpose of our study was to design and implement a standardized approach to identifying adherence barriers for youth with JIA across 7 pediatric rheumatology clinics through the Pediatric Rheumatology Care and Outcomes Improvement Network (PR-COIN) and to assess the frequency of adherence barriers in patients and their caregivers across treatment modalities.Methods.: An iterative process using coproduction among parents and providers of patients with JIA was used to design the Barriers Assessment Tool to screen for adherence barriers across 4 treatment modalities (i.e., oral medications, injectable medications, infusions, and physical/occupational therapy). This tool was implemented in 7 rheumatology clinics across the United States and patient responses were collected for analysis.Results.: Data were collected from 578 parents and 99 patients (n = 44 parent-child dyads). Seventy-seven percent (n = 444) of caregivers and 70% (n = 69) of patients reported at least 1 adherence barrier across all treatment components. The most commonly reported adherence barriers included worry about future consequences of therapy, pain, forgetting, side effects, and embarrassment related to the therapy. There was no significant difference between endorsement of barriers between parents and adolescents.Conclusion.: Implementing a standardized tool assessing adherence barriers in the JIA population across multiple clinical settings is feasible. Systematic screening sheds light on the factors that make adherence difficult in JIA and identifies targets for future adherence interventions in clinical practice.Keywords
This publication has 45 references indexed in Scilit:
- Randomized Trial of Tocilizumab in Systemic Juvenile Idiopathic ArthritisNew England Journal of Medicine, 2012
- Longitudinal Follow-up of Poor Inner-city Youth Between Ages 8 and 18: Intentions Versus RealityPediatrics, 2012
- Rates of malignancy associated with juvenile idiopathic arthritis and its treatmentArthritis & Rheumatism, 2012
- Burden of childhood-onset arthritisPediatric Rheumatology, 2010
- Development and validation of the Pediatric Epilepsy Medication Self-Management QuestionnaireEpilepsy & Behavior, 2010
- Medication Barriers Predict Adolescent Transplant Recipients' Adherence and Clinical Outcomes at 18-Month Follow-upJournal of Pediatric Psychology, 2010
- Brief Report: Barriers to Treatment Adherence in Pediatric Inflammatory Bowel DiseaseJournal of Pediatric Psychology, 2009
- Effects of adherence to treatment on short‐term outcomes in children with juvenile idiopathic arthritisArthritis Care & Research, 2007
- Improving adherence to medical regimens for juvenile rheumatoid arthritisPediatric Rheumatology, 2007
- Long‐term safety and efficacy of etanercept in children with polyarticular‐course juvenile rheumatoid arthritisArthritis & Rheumatism, 2006